Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 3.25% | $179.00M | CHF263.94B | 22.97% | 73 Outperform | |
| ASML Holding | 3.21% | $176.45M | $529.02B | 97.15% | 81 Outperform | |
| Nestlé SA | 2.33% | $128.20M | CHF201.15B | 2.25% | 71 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.82% | $100.21M | €248.69B | -18.89% | 78 Outperform | |
| Novartis | 1.62% | $88.90M | $295.46B | 43.41% | 80 Outperform | |
| Sony | 1.60% | $87.80M | ¥21.06T | -16.45% | 73 Outperform | |
| AstraZeneca | 1.53% | $84.41M | $300.81B | 24.33% | 80 Outperform | |
| Deutsche Telekom | 1.31% | $72.30M | €159.88B | -2.43% | 67 Neutral | |
| BHP Group Ltd | 1.27% | $70.12M | AU$263.86B | 47.44% | 68 Neutral | |
| SAFRAN SA | 1.24% | $68.01M | €132.66B | 27.23% | 67 Neutral |